Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SETDB1 | Q15047 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | SCARB1 | Q8WTV0 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20648361 | 0.94 | PTGER4 (0.42) | PTGER4MAPTCYP1A2CYP3A4HRH4 | |
| SCHEMBL20655221 | 0.93 | PIK3CD (0.36) | PTGER4CYP11B2MAPTHRH4EGLN2 | |
| SCHEMBL20648358 | 0.90 | CYP11B2 (0.34) | PTGER4CYP11B2CYP11B1SETDB1CASP3 | |
| SCHEMBL20655558 | 0.90 | STS (0.36) | PTGER4CYP11B2CYP11B1 | |
| SCHEMBL20655478 | 0.90 | CYP1A2 (0.40) | MAPTCYP1A2CYP3A4HRH4MEN1 | |
| SCHEMBL20648263 | 0.90 | PTGER4 (0.32) | PTGER4HRH4 | |
| SCHEMBL20114579 | 0.89 | L3MBTL1 (0.40) | PTGER4MAPTCYP1A2CYP3A4HRH4 | |
| SCHEMBL20792039 | 0.88 | PTGER4 (0.36) | PTGER4CYP11B2CYP11B1MAPTSETDB1 | |
| SCHEMBL20655561 | 0.88 | PTGER4 (0.43) | PTGER4MAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL20150412 | 0.88 | CASP3 (0.35) | PTGER4CYP11B2CYP11B1SETDB1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11005048-B2 | Organic molecules, in particular for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-05-11 | — | — | US | disclosed |
| EP-3530659-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-08-28 | — | — | EP | disclosed |
| EP-3431473-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-01-23 | — | — | EP | disclosed |
| US-20190019960-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-01-17 | — | — | US | disclosed |
| EP-3428164-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190019960-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, OR51E2, ORC3 | PTGER4 585/4885CYP11B2 830/4885CYP11B1 1100/4885 |
| US-11005048-B2 | Organic molecules, in particular for use in optoelectronic devices | OR10J3, OR51E2, ORC3 | PTGER4 585/4885CYP11B2 830/4885CYP11B1 1100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.